Events & Presentations

Featured Event
Date Event Details Remind Me
Sep 12, 2017
11:40 AM ET
Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

Upcoming Events

Details on upcoming events are not yet available. Please click here to be notified of all upcoming events.

Presentations
Date Title
Sep. 13, 2017
Apr. 20, 2017
Feb. 7, 2017
Archived Events
Date Event Details
Jul 13, 2017
3:30 PM ET
Singular Research Summer Conference
Mar 28, 2017
9:00 AM ET
Fourth Quarter and Full Year 2016 Financial Results and Business Update
Mar 15, 2017
11:30 AM PT
29th Annual ROTH Conference
Presentation
1.6 MB
Add to Briefcase
Feb 13, 2017
3:00 PM ET
BIO CEO & Investor Conference Webcast Presentation
Presentation
1.6 MB
Add to Briefcase
Feb 2, 2017
11:30 AM ET
VirtualInvestorConferences.com
Presentation
1.2 MB
Add to Briefcase
Dec 15, 2016
1:30 PM ET
Galectin Therapeutics 2016 Annual Meeting of Stockholders - Corporate Update Webcast

Galectin Therapeutics 2016 Annual Meeting of Stockholders - Corporate Update

Webcast to begin at approximately 1:30 p.m. ET on Thursday, December 15, 2016

The webcast may be accessed directly via the following link:  https://dentons.adobeconnect.com/galt_board/

The presentation may also be heard via teleconference by dialing 866-225-1342 (within the United States).

A list of international dial-in numbers can be found here:  https://www.tcconline.com/listNumbersByCode.action?confCode=8620018752

The passcode for participants is 8620018752

Please log in approximately 10 minutes before the event to ensure a timely connection.

Sep 27, 2016
5:30 PM ET
Business Update Conference Call & Webcast

Participant dial-in number: 1-888-317-6003
Pin number: 4681161
Webcast link:  http://services.choruscall.com/links/galt160927.html

Sep 12, 2016
3:50 PM ET
Rodman & Renshaw 18th Annual Global Investment Conference
May 21, 2015
2015 Annual Stockholder Meeting

Galectin Therapeutics (Nasdaq:GALT) hosted a corporate update webcast on Thursday, May 21, 2015, immediately following the business portion of the Company’s Annual Meeting of Stockholders. Peter Traber, M.D., president, chief executive officer and chief medical officer discussed the company’s pipeline of galectin inhibitor compounds and progress in development of treatments for liver fibrosis and cancer. View the video replay: http://galectintherapeutics.com/stockholder-meeting-webcast/

May 14, 2014
10:00 AM ET
2014 Annual Stockholder Meeting

Galectin Therapeutics (NASDAQ: GALT) held a webcast to provide an update following the Company's Annual Meeting of Shareholders. To view a PDF of the document referenced in the webcast, click here.

Add to Briefcase = add file to Briefcase